Skip to Content

Federated Hermes Kaufmann Small Cap IS FKAIX

Medalist Rating as of | See Federated Hermes Investment Hub
  • NAV / 1-Day Return 50.19  /  −0.10 %
  • Total Assets 4.2 Bil
  • Adj. Expense Ratio
    0.900%
  • Expense Ratio 0.900%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 0.28%
  • Turnover 31%

USD | NAV as of May 07, 2024 | 1-Day Return as of May 07, 2024, 10:22 PM GMT+0

Morningstar’s Analysis FKAIX

Will FKAIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Federated Hermes Kaufmann Small Cap IS’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FKAIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 22.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

argenx SE

3.28 142.5 Mil
Healthcare

Wingstop Inc

3.10 134.5 Mil
Consumer Cyclical

Fusion Pharmaceuticals Inc Ordinary Shares

2.49 108.2 Mil
Healthcare

IDEAYA Biosciences Inc

2.39 103.9 Mil
Healthcare

Hamilton Lane Inc Class A

2.25 97.5 Mil
Financial Services

Comfort Systems USA Inc

2.23 96.9 Mil
Industrials

Ares Management Corp Ordinary Shares - Class A

1.92 83.1 Mil
Financial Services

Arcturus Therapeutics Holdings Inc

1.71 74.2 Mil
Healthcare

Camtek Ltd

1.56 67.7 Mil
Technology

Merus NV

1.53 66.4 Mil
Healthcare